Cvi Holdings, LLC P Lx Pharma Inc. Transaction History

Cvi Holdings, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$1.22 - $4.38 $16,931 - $60,785	-13,878 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.18 - $5.15 $48,984 - $79,330	-15,404 Reduced 52.61%	13,878 $56,000
Q2 2018 Aug 14, 2018	SELL	$3.3 - $4.5 $55,486 - $75,663	-16,814 Reduced 36.48%	29,282 $116,000
Q1 2018 May 15, 2018	BUY	$3.2 - $7.43 $147,507 - $342,493	46,096 New	46,096 $154,000

61.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.